Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 8741-8750 of 13159

Page
per page
  1. Qc 1
    B5799 Qc 1
    Summary: threonine dehydrogenase (TDH) inhibitor
      <22.77 mg/mL
  2. NF 340
    B7508 NF 340
    Summary: P2Y11 antagonist
      <19.74 mg/mL
  3. GKT137831
    B4763 GKT137831
     8 Citation
    Target: NADPH Oxidases
    Summary: dual NADPH oxidase Nox1/Nox4 inhibitor
      ≥39.5 mg/mL
  4. AL 8697
    B7784 AL 8697
    Target: p38
    Summary: p38α inhibitor,potent and selective
      <40.24 mg/mL
  5. LB-100
    B4846 LB-100
    Summary: protein phosphatase 2A(PP2A)inhibitor
      ≥26.8 mg/mL
  6. Ischemin sodium salt
    B4917 Ischemin sodium salt
    Summary: CBP bromodomain inhibitor
      <35.74 mg/mL
  7. EC 144
    B4920 EC 144
    Target: HSP90
    Summary: High affinity, potent and selective Hsp90 inhibitor
      <41.39 mg/mL
  8. Entrectinib
    B5859 Entrectinib
    Target: Trk Receptors|ALK|ROS1
    Summary: Orally active inhibitor of ALK kinase
      ≥28.05 mg/mL
  9. AS601245
    B5942 AS601245
    Summary: c-Jun NH2-terminal protein kinase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥14.25 mg/mL
  10. Gap 26
    A1044 Gap 26
     24 Citation
    Target: Gap Junctions
    Summary: Gap junction blocker peptide, mapping to connexin 43 residue 63-75
      insoluble in EtOH; ≥155.1 mg/mL

Items 8741-8750 of 13159

Page
per page